Type 2 Diabetes Mellitus
📧 Sign up to get email alerts when something new happens for Type 2 Diabetes Mellitus.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2015-12-16FDA Approved: BASAGLAR KWIKPEN — Original Application (Eli Lilly and Company)
FDA approved BASAGLAR KWIKPEN (insulin glargine) by Eli Lilly in an Original Application as a long-acting insulin for glycemic control in ad…
-
CLINICAL_TRIALS trial_result · 2015-12-16Clinical Trial Update: Periodontal Treatment in Non-controlled Type 2 Diabetes Mellitus Patients. Clinical Trial [NA]
Clinical trial evaluating periodontal treatment in adults with non-controlled Type 2 diabetes mellitus and chronic periodontitis has complet…
-
CLINICAL_TRIALS trial_result · 2015-12-16Clinical Trial Update: Low Glycemic Index Diets vs. High Cereal Fibre Diets in Type 2 Diabetes [NA]
This clinical trial update reports on a completed comparison of low glycemic index diets versus high cereal fiber diets in participants with…
-
CLINICAL_TRIALS trial_result · 2015-12-15Clinical Trial Update: Effect of the DPP-4 Inhibitor Sitagliptin on Islet Function After Mixed Meal in Patients With Type 2 Diabetes [NA]
Clinical trial update examining the effect of the DPP-4 inhibitor sitagliptin on islet function after a mixed meal in adults with type 2 dia…
-
CLINICAL_TRIALS trial_result · 2015-12-15Clinical Trial Update: Study on Lixisenatide and Counterregulation to Hypoglycemia [Phase 4]
A Phase 4 clinical trial evaluating lixisenatide and counterregulation to hypoglycemia in type 2 diabetes has completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2015-12-15Clinical Trial Update: Motivational Interviewing and Cognitive Behavioral Therapy-based Intervention for Cardiovascular Disease Prevention Amongst American Indians With Diabetic and Depressive Symptoms [NA]
The study NCT01892124 completed, evaluating a motivational interviewing and cognitive-behavioral therapy–based intervention for cardiovascul…
-
CLINICAL_TRIALS trial_result · 2015-12-14Clinical Trial Update: Pharmacokinetics Study of Dipeptidyl Peptidase 4 Inhibitor to Control Type 2 Diabetes Mellitus [Phase 4]
Phase 4 pharmacokinetics study of a dipeptidyl peptidase-4 inhibitor in Type 2 diabetes mellitus has completed and posted results.
-
CLINICAL_TRIALS trial_result · 2015-12-14Clinical Trial Update: Effects of Adjunct Photodynamic Therapy in the Treatment of Type 2 Diabetic Patients With Chronic Periodontitis [NA]
Completed clinical trial assessing adjunct photodynamic therapy in adults with type 2 diabetes mellitus and chronic periodontitis.
-
CLINICAL_TRIALS trial_result · 2015-12-09Clinical Trial Update: Fruits, Vegetables, and Whole Grains: A Community-based Intervention [Phase 1]
This update reports completion of a Phase 1, community-based lifestyle intervention using fruits, vegetables, and whole grains, aimed at red…
-
CLINICAL_TRIALS trial_result · 2015-12-09Clinical Trial Update: SAFEGUARD: Pleiotropic Effects of Incretin Based Therapies [Phase 4]
Phase 4 study investigating pleiotropic effects of incretin-based therapies in type 2 diabetes mellitus has completed.
-
CLINICAL_TRIALS trial_result · 2015-12-09Clinical Trial Update: Peripheral Insulin Uptake in Type 2 Diabetes Mellitus and in Non-Diabetic Individuals
An update on a completed clinical trial examining peripheral insulin uptake in individuals with Type 2 Diabetes Mellitus and in non-diabetic…
-
CLINICAL_TRIALS trial_result · 2015-12-09Clinical Trial Update: The Medication Metronome Project - Study to Facilitate Follow-up Testing Resulting From Prescribed Medications to Improve Patient Safety and Care [NA]
This is a completed clinical trial update from Massachusetts General Hospital about a study aimed at improving patient safety through follow…
-
CLINICAL_TRIALS trial_result · 2015-12-09Clinical Trial Update: Liraglutide Use in Prader-Willi Syndrome [Phase 4]
A Phase 4 trial evaluating liraglutide for Prader-Willi syndrome (with Type 2 diabetes mellitus) has been terminated.
-
CLINICAL_TRIALS trial_result · 2015-12-09Clinical Trial Update: Effects of Exenatide in Type 2 Diabetic Patients With Congestive Heart Failure [Phase 4]
A Phase 4 clinical trial evaluating the effects of exenatide in adults with type 2 diabetes mellitus and congestive heart failure has comple…
-
CLINICAL_TRIALS trial_result · 2015-12-08Clinical Trial Update: Low Glycemic Index Diets (With Pulses) in Type 2 Diabetes [Phase 2]
Phase 2 clinical trial evaluating low glycemic index diets incorporating pulses in Type 2 diabetes has completed.
-
CLINICAL_TRIALS trial_result · 2015-12-08Clinical Trial Update: Effect of Bariatric Surgery on Gut Hormones Production and Cure of Type 2 Diabetes Mellitus
A clinical trial update examining how bariatric surgery influences gut hormone production and its potential to cure Type 2 Diabetes Mellitus…
-
CLINICAL_TRIALS trial_result · 2015-12-08Clinical Trial Update: Low Glycemic Index Diet (With Canola Oil) for Type 2 Diabetics [Phase 2]
This is a Phase 2 clinical trial update reporting the completion of a study evaluating a low glycemic index diet with canola oil in people w…
-
CLINICAL_TRIALS trial_result · 2015-12-07Clinical Trial Update: Educational Efficacy Assessment of a Serious Game to Teach Insulin Therapy to Primary Care Physicians [NA]
Completed study evaluating the educational efficacy of a serious game designed to teach primary care physicians how to manage insulin therap…
-
CLINICAL_TRIALS trial_result · 2015-12-07Clinical Trial Update: Phase 2b Multicenter, Randomized, Double-Blind, Placebo- and Active-Controlled, Parallel-Group Study to Assess the PD Response and Safety of Three Dose Levels of (PB1023) Injection Following 20 Weeks of Weekly SC Dosing in Adults With T2DM [Phase 2]
Phase 2b multicenter, randomized, double-blind trial evaluating three dose levels of PB1023 in adults with Type 2 Diabetes Mellitus has comp…
-
FDA approval · 2015-12-04FDA Approved: DAPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE — Supplemental Application (Prasco Laboratories)
FDA approved a supplemental application from Prasco Laboratories for a dapagliflozin and metformin hydrochloride product.
-
FDA approval · 2015-12-04FDA Approved: GLYXAMBI — Supplemental Application (Boehringer Ingelheim Pharmaceuticals, Inc.)
FDA approved a supplemental application for GLYXAMBI (empagliflozin and linagliptin) from Boehringer Ingelheim Pharmaceuticals, Inc.
-
FDA approval · 2015-12-04FDA Approved: SYNJARDY — Supplemental Application (Boehringer Ingelheim Pharmaceuticals, Inc.)
FDA approved a supplemental application for SYNJARDY (empagliflozin and metformin hydrochloride) from Boehringer Ingelheim Pharmaceuticals, …
-
CLINICAL_TRIALS trial_result · 2015-12-04Clinical Trial Update: The Effect of a Gastric Bypass on Type 2 Diabetes in the Morbidly Obese Patient
A completed clinical trial evaluating the impact of gastric bypass surgery on type 2 diabetes in morbidly obese patients.
-
CLINICAL_TRIALS trial_result · 2015-12-03Clinical Trial Update: Impact of Self-Monitoring Blood Glucose Frequency on Glycemic Control in Patients With Type 2 Diabetes [Phase 4]
A Phase 4 trial update evaluating whether different frequencies of self-monitoring blood glucose improve glycemic control in adults with Typ…
-
CLINICAL_TRIALS trial_result · 2015-12-03Clinical Trial Update: Improving Glycaemic Control With L-carnitine [Phase 2]
This entry summarizes a Phase 2 clinical trial sponsored by the University of Nottingham evaluating L-carnitine for improving glycemic contr…